Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 11,610
+60 (0.52%)
At close: Dec 19, 2025
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 177.25 billion as of December 19, 2025. Its market cap has decreased by -4.84% in one year.
Market Cap
177.25B
Enterprise Value
118.32B
Revenue
256.32B
Ranking
n/a
PE Ratio
11.86
Stock Price
11,610.00
Market Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 177.25B, an increase of 246.06%. That is a compound annual growth rate of 4.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 177.25B | -1.69% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | 254.96B | 8.09% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.22T |
| Celltrion | 40.37T |
| ALTEOGEN | 23.05T |
| ABL Bio | 10.29T |
| SK Biopharmaceuticals | 10.09T |
| Yuhan | 8.64T |
| LigaChem Biosciences | 6.25T |
| HLB Co., Ltd. | 6.05T |